From Financial Modeling Prep: 2025-05-01 07:00:00

The consensus price target for KKR & Co. Inc. (NYSE:KKR) has decreased from $135.46 to $119 over the past year, indicating potential concerns over market conditions or the company’s portfolio performance. KKR’s fundamentals remain strong, with robust cash flow and a strategic expansion into the life sciences sector through a $1.2 billion acquisition of Biotage. Anticipation is low for KKR’s upcoming first-quarter results, but a positive surprise could influence future analyst projections and price targets.



Read more at Financial Modeling Prep:: KKR & Co. Inc. (NYSE:KKR) Investment Insights